2021 Sina Medicine Annual Awards Officially Announced!
In 2021, China’s pharmaceutical and health industry continued to advance amidst the dual challenges of profound structural shifts and the COVID-19 pandemic. New business models emerged continuously, market concentration kept rising, internationalization accelerated, and industries related to vaccines, prevention and control, and testing saw rapid growth.
However, under the pressure of multiple factors, many pharmaceutical companies are experiencing growing pains, with traditional industries accelerating their transformation and innovation mechanisms continuously improving.
As we move past 2021 and enter the post-pandemic era, how China’s pharmaceutical and health industries can break through existing constraints, seize new opportunities, and identify new growth engines has become a focal point of intense industry discussion.
To document and bear witness to the trajectory of transformative changes in our times, and to uncover and highlight exemplary role models, Sina Medicine has, as scheduled, begun preparations in the second half of this year for its annual “Role Model” selection campaign.
On December 15, after a four-month process involving rigorous recommendation and evaluation, registration screening, online voting, and expert review, “2021 Sina Medicine Annual Overall Review Rankings“The list has been officially unveiled. This list is based on”People, Enterprises, Philanthropy, Innovative Drugs/TherapiesFour categories of awards and eleven major rankings have conducted a panoramic scan of China’s pharmaceutical industry, adding numerous evaluation dimensions to address the hotspots and focal points of industry development in 2021.
Regarding the annual “Influential” Figures, we have added a “Social Contribution” dimension to the industry influence criteria, aiming to select a group of advanced role models who have made significant impacts from the industry to society as a whole;
In the annual “Pioneering Leaders” category, we emphasized candidates’ “innovative mindset, outstanding performance, and rapid progress,” enabling a cohort of emerging technologies and rising vaccine stars to make their debut on the list as the “new wave.”
On the “Enterprise” list, we not only spotlight influential benchmarks with outstanding “revenue performance,” but also aim to uncover future stars that demonstrate “product potential,” “market potential,” and a strong focus on “R&D investment” and “team building.”
Meanwhile, we are continuously selecting benchmark enterprises among traditional companies, medical device manufacturers, and internet healthcare firms that demonstrate “innovative transformation power,” actively embrace emerging internet technologies, continually revitalize their brands, and consistently provide novel solutions for industry development.
It is worth mentioning that, as a ranking list that has focused on the industry’s “social responsibility” and “public welfare projects” for many consecutive years, “Sina Medicine — 2021 Outstanding Public Welfare Project in the Pharmaceutical Industry“This year has witnessed a qualitative leap in impact, driven by record-high levels of corporate attention and participation. The aim is to leverage the evaluation process to further ‘expand the reach of public welfare initiatives, mobilize broader societal engagement, and help patients effectively address their practical needs.’”
As the most prominent new highlight of this list—2021 Most Watched Innovative Drugs/Therapies, covering major R&D highlights in COVID-19, oncology, autoimmune diseases, and more, having undergoneOver 40 Experts, after multiple rounds of voting, the finalOver 50 Blockbuster Drugs/Therapies That Break Through Treatment Dilemmas and Ignite Hope for a Cureselected from among them, with the aim of delivering greater and better benefits to patients...
Note: This selection is supported by multiple media outlets and data agencies, including Sinohealth Technology.
The following is “2021 Sina Medicine Annual Awards"List of Winners (ranked in alphabetical order by the Pinyin of the winners' names/companies):"
Person of the Year Award
Corporate Award
Public Welfare and Social Responsibility Award
Product Award
Note: The aforementioned award recipients and awarded organizations shall contact the organizer by 18:00 on December 22, 2021, to arrange for the delivery of trophies. Failure to do so within the specified timeframe will be deemed as voluntary forfeiture.
